Hypertriglyceridemia as a possible cause of coma: a case report
- 3.9k Downloads
Many studies suggest that elevated triglyceride levels are associated with increased long-term risk of stroke, including transient ischemic attacks. In addition, elevated triglyceride levels independently contribute to plasma viscosity and decreased blood flow. However, no consensus has been reached regarding the significance of hypertriglyceridemia as an independent risk factor for ischemic stroke.
We report the case of a patient admitted to our hospital for sudden onset of coma. Laboratory test results revealed he had high blood glucose (28.2mmol/L), high glycated hemoglobin (11.4 percent), considerably high serum triglyceride levels (171.5mmol/L; type V hyperlipoproteinemia), and high plasma viscosity (1.90mPa/s) with normal β-hydroxybutyric acid levels. His triglyceride levels decreased after administering intravenous fluids. Our patient’s consciousness level improved gradually over three days. All serum lipid levels decreased seven days after admission.
The findings in our patient’s case are likely explained by triglyceride-mediated hyperviscosity causing a transient ischemic attack. In the present report we suggest that when several tests do not reveal the cause of stroke-like symptoms, measurement of plasma viscosity may be informative.
KeywordsHypertriglyceridemia Plasma viscosity Alcohol Diabetes mellitus Transient ischemic attack
Elevated triglyceride levels are associated with increased long-term risk of ischemic stroke. Short-term complications include pancreatitis, which is an emergent problem, and other complications that have been reported in familial hypertriglyceridemia, including recent memory loss, abdominal pain, dyspnea, eruptive xanthoma, flushing after alcohol consumption, and lipemia retinalis. However, no consensus has been reached regarding the significance of hypertriglyceridemia as an independent risk factor for ischemic stroke. Here, we report the case of a patient with sudden coma likely caused by triglyceride-mediated hyperviscosity.
A comatose 56-year-old Japanese man with no significant familial medical history was admitted to the emergency room. He delivered newspapers and usually consumed alcohol two hours before delivery. According to colleagues, during his usual morning routine, he suddenly fell on his back. On admission, his temperature was 36.0°C, pulse rate 77 beats/min, blood pressure 153/94mmHg and Glasgow Coma Scale score was E2V2M1. On examination, splenohepatomegaly was detected, but heart murmur, chest rales, tongue biting, incontinence, diaphoresis, seizure, and xanthoma were not evident. He maintained a balanced diet and was not obese (height 164cm, weight 58.8kg and body mass index 21.9kg/m2).
We report the case of a patient with sudden coma likely caused by triglyceride-mediated hyperviscosity. Hypertriglyceridemia may lead to ischemic stroke through its contribution to atherosclerosis and/or thrombogenicity. Studies suggest that hypertriglyceridemia fosters the development of atherosclerosis via several mechanisms, namely promotion of atherosclerosis, endothelial dysfunction, oxidative stress due to lipid-derived free radicals, impairment of endothelial-dependent vasodilatation, association with elevated atherosclerosis markers (C-reactive protein, fibrinogen levels and circulating adhesion molecules), promotion of thrombogenicity, elevated plasma viscosity, elevated plasma fibrinogen levels, lowered fibrinolytic activity, elevated levels of clotting factor Xc compared to normolipidemic controls, and elevated fibrinogen levels. Among them, Rosenson et al. reported that elevated triglyceride levels independently contribute to plasma viscosity and decrease blood flow, and Tomiyama et al. reported that plasma viscosity is associated with cerebral blood flow. Following high-dose intravenous immunoglobulin therapy, blood and plasma viscosity can increase, and the risk of thromboembolism (including stroke) increases when serum viscosity exceeds a threshold after high-dose intravenous immunoglobulin therapy. Therefore, hypertriglyceridemia may increase the risk of stroke by inducing a prothrombotic state through its effects on plasma viscosity.
Hypertriglyceridemia can occur because of obesity, poorly controlled diabetes mellitus, alcohol misuse, and familial disease. In our patient’s case, he had no family history, and therefore, the causes of hypertriglyceridemia were likely to be poor control of diabetes mellitus and alcohol misuse. Many case reports and series have described apheresis for hypertriglyceridemia. However, we did not pursue this treatment because our patient responded to fluid therapy and did not exhibit pancreatitis.
The effects of alcohol and alcohol withdrawal cannot be ruled out in our patient. However, people with chronic alcoholism may demonstrate little clinical evidence of intoxication even with blood alcohol levels >22.2mmol/L. In addition, alcohol withdrawal cannot explain the symptoms, because withdrawal symptoms typically begin four to 12 hours after alcohol cessation. Our patient’s symptoms appeared two hours after consumption, and his vital signs and physical characteristics did not indicate alcohol withdrawal. With regard to hyperglycemia, symptoms of hyperosmolar hyperglycemic state develop insidiously with polyuria, polydipsia, and weight loss, often persisting for several days before hospital admission, and diabetic ketoacidosis usually evolves more rapidly, over a 24-hour period. In our patient’s case, his symptoms developed too quickly and his β-hydroxybutyric acid level was normal. Therefore, the probability of hyperglycemia being the direct cause of his coma is low.
We report the case of a patient who entered coma, likely caused by triglyceride-mediated hyperviscosity causing a transient ischemic attack. We suggest that when several tests do not reveal the cause of stroke-like symptoms, measurement of plasma viscosity may be informative.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
We would like to acknowledge Makiko Hirahata and Shigemi Kobayashi for their assistance.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.